Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2026)
Lucid Diagnostics (LUCD) posted Change in Receivables of $46000.0 for Q1 2026, down 52.08% on a QoQ basis from $96000.0 in Q4 2025, and up 187.5% year-over-year from $16000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2026) Analysis & Trends
Lucid Diagnostics' Change in Receivables history runs 5 years deep, the most recent figure standing at $46000.0 for Q1 2026.
- Quarterly Change in Receivables rose 187.5% year-over-year to $46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $631000.0 (up 5158.33% YoY) and the FY2025 annual result came in at $601000.0, changed N/A from the prior year.
- Change in Receivables was $46000.0 for Q1 2026 at Lucid Diagnostics, down from $96000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $312000.0 in Q2 2025 and bottomed at -$122000.0 in Q3 2024.
- A 5-year average of $28941.2 and a median of $10000.0 in 2023 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 1287.5% in 2024, while the deepest fall reached 771.43% in 2024.
- Lucid Diagnostics' Change in Receivables stood at -$14000.0 in 2022, then jumped by 271.43% to $24000.0 in 2023, then plunged by 70.83% to $7000.0 in 2024, then jumped by 1271.43% to $96000.0 in 2025, then plunged by 52.08% to $46000.0 in 2026.
- Business Quant data shows LUCD's Change in Receivables at $46000.0 in Q1 2026, $96000.0 in Q4 2025, and $177000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Dec 31, 2023 | 24,000.00 |